Stephen J. McAndrew

SVP Bus. Strat. & Dev., Outlook Therapeutics, Inc.

Companies

Sonnet BioTherapeutics Holdings, Inc.Chief Business Officer Feb 21, 2025 to now¹
Outlook Therapeutics, Inc.SVP Bus. Strat. & Dev. May 12, 2016 to Oct 24, 2018²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Sonnet BioTherapeutics Holdings, Inc.0 shares³Dec 2, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 2, 2025Returned to company 6,446 shares of Sonnet BioTherapeutics Holdings, Inc.³
Jul 11, 2025Granted 6,000 shares of Sonnet BioTherapeutics Holdings, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSonnet BioTherapeutics Holdings, Inc., Chief Business Officer
2
SEC EDGAROutlook Therapeutics, Inc., SVP Bus. Strat. & Dev.
3
SEC EDGARSonnet BioTherapeutics Holdings, Inc. shares after the filing of Dec 2, 2025
4
SEC EDGARForm 4 filed Jul 15, 2025